PICO Venture Partners, a Jerusalem-based, early-stage venture capital firm, has closed its second fund with USD80 million in capital commitments. PICO now manages USD130 million across two funds. Founded in 2015, the firm invests in early-stage startups seeking to upend broken business models in sizeable industries. Rather than focusing on

Prestige Funds has listed its second Luxembourg direct lending fund, the Prime Alternative Finance Fund (PRALTF), on Euronext Dublin. The share classes include hedged EUR, USD, CHF, SEK as well as GBP based share classes and have accumulation or distribution options all operating with no performance fee and typically without

Splio has closed an additional EUR10 million funding round led by Ring Capital, a fund specialised in financing French tech scale-ups, with the participation of Swen Capital Partners and Splio’s historic investors, BPI France and Amundi PEF.   The company, which has offices in Europe and in China, presently offers

Enhanced Healthcare Partners (EHP), a New York-based private equity firm focused on investing in middle-market healthcare businesses, has closed Enhanced Healthcare Partners with USD300 million of committed capital with access to USD600 million in total equity to invest. The Fund will invest in founder and entrepreneur-led lower middle-market healthcare businesses

Clients of Connection Capital, a specialist private client investment business, have invested EUR5.2 million in the final close of a European Collateralised Loan Obligation (CLO) fund managed by Permira Debt Managers (PDM). The Permira Sigma V Fund targets a high cash yield from a diversified portfolio of senior secured European

Colorcon has launched Colorcon Ventures to invest in promising companies in the pharmaceutical industry. Colorcon’s business focus is on advanced coating systems, modified release technologies and functional excipients for use in pharmaceutical immediate and modified release dosage forms.   Colorcon Ventures is a USD50 million venture fund focused on startups

European debt investor Permira Debt Managers (PDM) has held the the final close of its fifth structured credit fund Permira Sigma V (Sigma V). Sigma V will continue the successes of the Sigma strategy, investing long-term capital in European CLOs, in both the primary and secondary markets. The Fund specialises

Plans for a cleaner and healthier Britain stepped up a gear today, as Ministers announced more than half a billion pounds of investment in green technologies. The Treasury has launched a GBP400 million fund, CIIF, to bolster Britain’s electric vehicle charging infrastructure, with the first GBP70 million provided by government

MJ Hudson has advised 4BIO Partners LLP (4BIO) on the establishment of a closed-ended venture capital fund. 4BIO is a London-based investment firm that invests in venture capital and public equities in life sciences focussing on gene, cell and RNA-based therapies. The fund focuses on investments in unlisted life sciences